Baudax Bio Balance Sheet Health
Financial Health criteria checks 0/6
Baudax Bio has a total shareholder equity of $-1.2M and total debt of $5.2M, which brings its debt-to-equity ratio to -436.4%. Its total assets and total liabilities are $20.6M and $21.8M respectively.
Key information
-436.4%
Debt to equity ratio
US$5.23m
Debt
| Interest coverage ratio | n/a |
| Cash | US$363.00k |
| Equity | -US$1.20m |
| Total liabilities | US$21.78m |
| Total assets | US$20.58m |
Recent financial health updates
Recent updates
Baudax Bio stock down after pricing $6.2M equity offering
Aug 30Baudax Bio to get US patent linked to pain drug Anjeso
Aug 22Baudax Bio GAAP EPS of -$1.05 beats by $0.22, revenue of $0.3M
Aug 11Cosette Pharmaceuticals appoints Rick Casten as CFO
Jul 06Baudax Bio: Looking For A Turnaround In Strong COVID-19 Headwinds
Sep 09A First Look At Baudax Bio
May 30Baudax Bio EPS misses by $0.08, misses on revenue
May 05Baudax Bio's Anjeso shows efficacy in pain management for total knee arthroplasty
Apr 26Have Insiders Been Buying Baudax Bio, Inc. (NASDAQ:BXRX) Shares?
Feb 17
Baudax Bio EPS of $0.62
Nov 09Baudax Bio: Why I'm Catching This Falling Knife
Nov 03Financial Position Analysis
Short Term Liabilities: BXRX.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BXRX.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BXRX.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: BXRX.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if BXRX.Q has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BXRX.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.